Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant

Experimental and Clinical Transplantation

Volumn 6, Issue 1, 2008, Pages 42-47

  Elmagd, Mogahid M Abu ^a   Bakr, Mohammed A ^a   Metwally, Abdel Hameed A ^a   El Wahab, Ahmad Mabd ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Diabetes; Graft survival; Immunosuppression; Kidney; Transplant

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CHOLESTEROL; CREATININE; CYCLOSPORIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT; PREDNISOLONE; RAPAMYCIN; STEROID; TACROLIMUS; CALCINEURIN; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADOLESCENT; ADULT; AGE; ANAMNESIS; ARTICLE; BLOOD CELL COUNT; CHOLESTEROL BLOOD LEVEL; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; CORRELATION FUNCTION; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIET RESTRICTION; DIET THERAPY; EGYPT; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; ISCHEMIC HEART DISEASE; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; POSTPRANDIAL STATE; PREDICTION; RISK FACTOR; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; URINALYSIS; CHILD; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; DRUG ANTAGONISM; GENETICS; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; TIME;

ADOLESCENT; ADULT; AGE FACTORS; CALCINEURIN; CHILD; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HEPATITIS C; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE COMPLICATIONS; STEROIDS; TIME FACTORS;

EID: 46049095104     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Shah A, Kendall G, Demme RA, et al. Home glucometer monitoring markedly improves diagnosis of post renal transplant diabetes mellitus in renal transplant recipients. Transplantation. 2005;80(6):775-781.
2. Cosio FG, Pesavento TE, Osei K, Henry ML, Ferguson RM. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years. Kidney Int. 2001;59(2):732-737.
3. Reisaeter AV, Hartmann A. Risk factors and incidence of posttransplant diabetes mellitus. Transplant Proc. 2001;33(suppl 5A):8S-18S.
4. Delaunay F, Khan A, Cintra A, et al. Pancreatic beta cells are important targets for the diabetogenic effects of glucocorticoids. J Clin Invest. 1997;100(8):2094-2098.
5. Markell M. Clinical impact of posttransplant diabetes mellitus. Transplant Proc 2001;33(suppl 5A): 19S-22S.
6. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31-41.
7. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int. 1993;44(2):411-422.
8. Ravindran V, Baboolal K, Moore R. Post transplant diabetes mellitus after renal transplantation: the emerging clinical-challenge. Yonsei Med J. 2004;45(6):1059-1064.
9. Schiel R, Heinrich S, Steiner T, Ott U, Stein G. Post-transplant diabetes mellitus: risk factors, frequenry of transplant rejections, and long-term prognosis. Clin Exp Nephrol. 2005;9(2):164-169.
10. Cho YM, Park KS, Jung HS, et al. High incidence of tacrolimus-associated posttransplantation diabetes in the Korean renal allograft recipients according to American Diabetes Association criteria. Diabetes Care. 2003;26(4):1123-1128.
11. Montori VM, Basu A, Erwin PJ, Velosa JA, Gabriel SE, Kudva YC. Posttransplantation diabetes: a systematic review of the literature. Diabetes Care. 2002;25(3):583-592.
12. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant. 2003;3(2):178-185.
13. Marcén R, Morales JM, del Castillo D, et al, Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years. Transplant Proc. 2006;38(10):3530-3532.
14. Bayés B, Granada ML, Pastor MC, et al. Obesity, adiponectin and inflammation as predictors of new-onset diabetes mellitus after kidney transplantation. Am J Transplant. 2007;7(2):416-422.
15. Abbott KC, Bernet VJ, Agodoa LY, Yuan CM. Differing manifestations of hepatitis C and tacrolimus on hospitalized diabetes mellitus occurring after kidney transplantation. Ann Epidemiol. 2005; 15(8):558-563,
16. Gentil MA, López M, González-Roncero F, et al. Hepatitis C and the incidence of diabetes mellitus after renal transplant: influence of new immunosuppression protocols. Transplant Proc. 2003; 35(5):1748-1750.
17. Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol. 1998;26(1):30-33.
18. Hjelmesaeth J, Hartmann A, Kofstad J, Egeland T, Stenstrøm J, Fauchald P. Tapering off prednisolone and cyclosporin the first year after renal transplantation: the effect on glucose tolerance. Nephrol Dial Transplant. 2001;16(4):829-835.
19. Vincenti F, Laskow DA, Neylan JF, Mendez R, Matas AJ. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group. Transplantation. 1996;61(11):1576-1581.
20. Ippoliti GB, Vigandò M. Calcineurin inhibitors and mechanisms that are responsible for the appearance of post-transplant diabetes mellitus [in Italian]. G Ital Nefrol. 2003;20(suppl 25):S11-S14.
21. Vincenti F, Friman S, Scheuermann E, et al. Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus. Am J Transplant. 2007;7(6):1506-1514. Erratum in: Am J Transplant. 2008;8(4):908. dosage error in text. Am J Transplant. 2008;8(1):1.
22. Kamar N, Mariat C, Delahousse M, et al. Diabetes mellitus after kidney transplantation: a French multicentre observational study. Nephrol Dial Transplant. 2007;22(7):1986-1993.
23. van Hooff JP, Christiaans MH, van Duijnhoven EM. Evaluating mechanisms of post-transplant diabetes mellitus. Nephrol Dial Transplant. 2004;19(suppl 6):vi8-vi12.
24. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(5)(suppl 3):S112-S119.
25. American Diabetes Association: Diabetic nephropathy. Diabetes Care 2002; 25:585-S89.
26. Partanen J, Niskanen L, Lehtinen J, Mervaala E, Siitonen O, Uusitupa M. Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. N Engl J Med. 1995;333(2):89-94.
27. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia. 1993;36(2):150-154.
28. Kasiske BL, Guijarro, C, Massy ZA, Wiederkehr MR, Ma JZ. Cardiovascular disease after renal transplantation. J Am Soc Nephrol. 1996;7(1):158-165.
29. Sumrani NB, Delaney V, Ding ZK, et al. Diabetes mellitus after renal transplantation in the cyclosporine era-an analysis of risk factors. Transplantation. 1991;51(2):343-347.
30. Miles AM, Sumrani N, Horowitz R, et al. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes? Transplantation. 1998;65(3):380-384.
31. Roth D, Milgrom M, Esquenazi V, Fuller L, Burke G, Miller J. Posttransplant hyperglycemia. Increased incidence in cyclosporine-treated renal allograft recipients. Transplantation. 1989;47(2):278-281.
32. Weir MR, Fink JC. Risk for posttransplant Diabetes mellitus with current immunosuppressive medications. Am J Kidney Dis. 1999;34(1):1-13.
33. Jindal RM, Hjelmesaeth J. Impact and management of posttransplant diabetes mellitus. Transplantation. 2000;70(11)(suppl):SS58-SS63.
34. Luna B, Feinglos MN. Oral agents in the management of type 2 diabetes mellitus. Am Fam Physician. 2001;63(9)1747-1756.